Evidence map›Paper›PMID 21496245›Full record

ArticleBMC complementary and alternative medicine2011

Use of multivitamins, folic acid and herbal supplements among breast cancer survivors: the black women's health study.

Mireille Bright-Gbebry, Kepher H Makambi, JoyAnn Phillips Rohan, Adana A Llanos, Lynn Rosenberg, Julie R Palmer, Lucile L Adams-Campbell

Registry-linked trialAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06137833 (Clinical Study on Wide Spectrum Micronutrients Supplementation in Patients With Cancer Related Fatigue During Neoadjuvant and Adjuvant Chemotherapy), which is not on this map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06137833 narecruitingnot on this mapstarted 2023, after this paper: background citation

Clinical Study on Wide Spectrum Micronutrients Supplementation in Patients With Cancer Related Fatigue During Neoadjuvant and Adjuvant Chemotherapy

TypeinterventionalSponsorPharmanutra S.p.a.Ran2023 to 2025Enrolled92ConditionsFatigue, Breast CancerArmsAPPOPRTAL®, Placebo
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Guideline
  2. Guideline
  3. Pooled it
  4. Article
  5. Large-scale North American cancer survivorship surveys: 2011-2019 update.Journal of cancer survivorship : research and practice · 2022
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Expectations from an integrative medicine consultation in breast cancer care: a registry protocol-based study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2015
    Article
  15. Review
  16. Article
  17. Curcumin induces apoptosis in breast cancer cells and inhibits tumor growth in vitro and in vivo.International journal of clinical and experimental pathology · 2014
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mireille Bright-GbebryLombardi Comprehensive Cancer Center, Georgetown University, 3970 Reservoir Road, NW, Research Building, E501, Washington, DC 20057, USA.
Kepher H Makambi
JoyAnn Phillips Rohan
Adana A Llanos
Lynn Rosenberg
Julie R Palmer
Lucile L Adams-Campbell

Funding

FOLLOW-UP STUDY FOR CAUSES OF ILLNESS IN BLACK WOMENR01CA058420 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ROSENBERG, LYNN · 1999 to 2013
$20.7M
TRAINING GRANT IN TUMOR BIOLOGYT32CA009686 · NCI · GEORGETOWN UNIVERSITY · PI ANNA Tate RIEGEL, DAVID J ROBBINS · 1996 to 2026
$10.8M
NCI NIH HHS R01 CA058420NCI NIH HHS R01 CA58420NCI NIH HHS T32 CA009686
6 · The paper itself

Abstract

backgroundComplementary and alternative medicine (CAM) use, including herbals and multivitamin supplements, is quite common in the U.S., and has been shown to be highest in breast cancer survivors. However, limited data are currently available for CAM usage among African Americans. Thus, we sought to determine the prevalence of multivitamins, folic acid and herbal supplement usage in African American breast cancer survivors, and to compare the characteristics of users and nonusers.

methodsA cohort study of breast cancer survivors, who completed the 1999 Black Women's Health Study questionnaire and self-reported having been diagnosed with breast cancer between 1995 and 1999, comprised the study population. In this study, the intake of natural herbs, multivitamins and folic acid at least three days per week within the past two years was used as a proxy for typical usage of this complimentary alternative medicine (CAM) modality.

resultsA total of 998 breast cancer survivors were identified. Overall, 68.2% had used either herbals or multivitamin supplements or both. The three most frequently used herbals were garlic (21.2%), gingko (12.0%), and echinacea (9.4%). The multivariate analysis determined that single marital status (OR=1.58; 95%CI: 1.04-2.41), and alcohol consumption of 1-3 drinks per week (OR=1.86, 95%CI: 1.28-2.68) were significantly associated with increased herbal use. Multivitamin use was significantly lower among obese women (OR=0.66, 95%CI: 0.46-0.94) and current smokers (OR=0.53, 95%CI: 0.34-0.82).

conclusionsA significant number of African American breast cancer survivors are using herbals and multivitamins as CAM modality. Additional research is needed to understand the impact of herbals and multivitamins in African American breast cancer survivors.

Indexed as

Black or African AmericanAdultAgedBreast NeoplasmsCohort StudiesComplementary TherapiesDietary SupplementsFemaleFolic AcidHumansMiddle AgedPlant PreparationsSurvivorsVitaminsWomen's HealthYoung AdultFolic AcidPlant PreparationsVitamins

Identifiers

PMID21496245
PMCPMC3095573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.